quadriplegia: Paralysis of all four limbs. [database_cross_reference: NCIT:P378]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
255 |
4. Check minimum number of eventsNone |
255 |
5. Include endpointsNone |
255 |
6. Filter based on genotype QC (FinnGen only) |
255 |
Control definitions (FinnGen only)
- Control exclude
- G6_CPETAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Tetraplegia
based on the number of shared cases.
Similar with more cases:
- Cerebral palsy and other paralytic syndromes
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4087 | 1500 | 2554 |
| Only index persons | 3242 | 1232 | 2010 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.04 | 0.07 |
| Only index persons | 0.06 | 0.05 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 50.34 | 49.30 | 50.77 |
| Only index persons | 48.83 | 47.36 | 49.72 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 255 | 97 | 158 |
| Unadjusted period prevalence (%) | 0.06 | 0.03 | 0.07 |
| Median age at first event (years) | 52.84 | 44.32 | 58.08 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 230
- Matched controls
- 2299
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G82.5
ICD-10 Finland
Tetraplegia, unspecified
+∞
192.8
157
*
G82.4
ICD-10 Finland
Spastic tetraplegia
+∞
100.6
89
*
M03BX01
ATC
baclofen; systemic
121.4
77.1
80
10
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
894.3
69.9
65
*
G82.2
ICD-10 Finland
Paraplegia, unspecified
+∞
45.3
42
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
31.3
44.3
59
25
L89
ICD-10 Finland
Decubitus ulcer and pressure area
33.2
39.8
52
20
S14.0
ICD-10 Finland
Concussion and oedema of cervical spinal cord
447.6
39.3
38
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
34.1
37.8
49
18
N18
ICPC
Paralysis/weakness
35.2
37.4
48
17
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
212.0
35.8
36
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
8.0
35.4
93
180
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
+∞
34.2
32
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
13.1
33.6
62
63
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
54.7
31.7
37
8
R4120
NOMESCO Finland
Occupational therapy
12.7
30.7
57
58
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
17.5
30.1
48
34
SPAT1229
SPAT
Assessment of need for aid
11.6
29.7
58
65
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
34.6
29.6
38
13
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
13.4
29.5
53
50
R33
ICD-10 Finland
Retention of urine
8.1
27.7
68
113
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
6.9
27.7
78
159
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
31.4
26.7
35
13
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
82.3
26.4
29
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
7.4
26.1
68
123
XKC03
NOMESCO Finland
Water cystometry
21.4
25.8
38
21
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
6.1
25.5
79
180
A28
ICPC
Limited function/disability NOS
6.5
25.4
74
156
L28
ICPC
Limited function/disability (L)
6.2
24.1
73
160
N03AX16
ATC
pregabalin; oral
4.7
23.0
96
302
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
69.6
22.3
25
*
R1250
NOMESCO Finland
Evaluation of functional capability
20.0
22.1
33
19
AA1AD
NOMESCO Finland
CT of head and brain
4.6
22.0
93
293
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
29.9
21.9
29
11
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.8
21.9
60
114
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
+∞
21.2
20
*
J01EA01
ATC
trimethoprim; systemic
4.4
20.9
95
319
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.8
20.9
65
145
N03AE01
ATC
clonazepam; systemic
9.1
20.6
45
60
UKC02
NOMESCO Finland
Cystoscopy
4.8
20.5
80
230
TKC20
NOMESCO Finland
Catheterisation of bladder
7.2
20.2
52
90
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.5
20.1
50
82
Z43.5
ICD-10 Finland
Attention to cystostomy
60.4
19.3
22
*
SPAT1167
SPAT
Insertion of urinary catheter
12.3
18.7
34
32
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
18.7
104
408
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
6.5
18.2
50
94
J01MA02
ATC
ciprofloxacin; systemic
3.5
18.2
126
588
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
194.2
17.8
18
*
J01MA12
ATC
levofloxacin; systemic
4.1
17.7
81
266
N03AX12
ATC
gabapentin; oral
4.5
17.6
71
207
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.6
17.2
101
408
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.3
16.9
72
220
NA1AD
NOMESCO Finland
Cervical spine CT examination
9.8
16.7
34
40
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.6
16.2
62
170
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
+∞
15.8
15
*
G82.3
ICD-10 Finland
Flaccid tetraplegia
+∞
15.8
15
*
A46
ICD-10 Finland
Erysipelas
4.6
15.7
60
164
T91.1
ICD-10 Finland
Sequelae of fracture of spine
171.0
15.7
16
*
QBG10
NOMESCO Finland
Excision and repair of bedsore of trunk
171.0
15.7
16
*
N30.0
ICD-10 Finland
Acute cystitis
4.7
15.3
57
151
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
48.5
15.3
18
*
N28
ICPC
Limited function/disability (N)
22.9
14.9
21
10
S97
ICPC
Chronic ulcer skin
7.9
14.8
34
49
S14.1
ICD-10 Finland
Other and unspecified injuries of cervical spinal cord
+∞
14.7
14
*
ABD40
NOMESCO Finland
Implantation of spinal injection device
+∞
14.7
14
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
14.7
14.6
24
18
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
8.9
14.1
30
38
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
32.3
14.1
18
6
N99
ICPC
Neurological disease other
25.7
14.0
19
8
K59.09
ICD-10 Finland
Constipation, unspecified
7.0
14.0
35
57
N81
ICPC
Injury nervous system other
80.0
13.7
15
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.3
13.7
86
354
G82.0
ICD-10 Finland
Flaccid paraplegia
+∞
13.7
13
*
9072A
ICD-9 Finland
Late effects of injuries to the nervous system, Late effect of spinal cord injury
+∞
13.7
13
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.8
13.4
63
206
U05
ICPC
Urination problems other
8.0
13.3
30
42
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.9
13.1
45
109
J01MA06
ATC
norfloxacin; oral
4.3
13.1
52
146
J01XX05
ATC
methenamine; oral
53.1
13.0
15
*
GBB00
NOMESCO Finland
Tracheostomy
16.7
12.9
20
13
U07
ICPC
Urine symptom/complaint other
7.9
12.8
29
41
X58
ICD-10 Finland
Exposure to other specified factors
3.9
12.7
57
178
NAJ10
NOMESCO Finland
Anterior reduction of fracture of cervical spine
74.0
12.7
14
*
XKD03
NOMESCO Finland
Urethral pressure profilometry
14.3
12.7
21
16
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
12.6
12
*
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
137.1
12.6
13
*
R4110
NOMESCO Finland
Physiotherapy
3.1
12.5
85
365
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
7.4
12.2
29
44
S12.7
ICD-10 Finland
Multiple fractures of cervical spine
68.5
11.7
13
*
U29
ICPC
Urinary symptom/complaint other
14.7
11.7
19
14
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
+∞
11.5
11
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
11.5
88
406
N05BA01
ATC
diazepam; systemic, rectal
3.7
11.3
53
171
M48.0
ICD-10 Finland
Spinal stenosis
4.4
11.2
42
111
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.1
11.1
46
133
T90.5
ICD-10 Finland
Sequelae of intracranial injury
16.6
11.0
17
11
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
7.7
10.9
25
36
J01CA08
ATC
pivmecillinam; oral
2.8
10.8
85
395
A06AD11
ATC
lactulose; oral
3.5
10.8
54
183
QBG00
NOMESCO Finland
Debridement of bedsore of trunk
62.9
10.7
12
*
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
62.9
10.7
12
*
N02AX02
ATC
tramadol; systemic, rectal
2.6
10.6
115
639
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.9
10.5
18
15
W19
ICD-10 Finland
Unspecified fall
4.2
10.5
41
112
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.5
10.5
27
46
G80.3
ICD-10 Finland
Dyskinetic cerebral palsy
+∞
10.5
10
*
N06AX21
ATC
duloxetine; oral
4.0
10.2
43
126
SPAT1262
SPAT
Handing over of treatment supplies
3.2
10.1
60
231
R5140
NOMESCO Finland
Monitoring the use of the aid
4.0
10.1
42
122
W17
ICD-10 Finland
Other fall from one level to another
6.1
10.0
27
49
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
11.4
10.0
18
17
R25.2
ICD-10 Finland
Cramp and spasm
10.7
9.7
18
18
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.3
9.7
36
94
NFL22
NOMESCO Finland
Myotomy or tenotomy of hip or thigh
104.0
9.5
10
*
A08
ICPC
Swelling
7.8
9.5
21
29
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
10.2
9.5
18
19
G82
ICD-10 Finland
Paraplegia and tetraplegia
+∞
9.4
9
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
8.3
9.3
20
26
N02AA05
ATC
oxycodone; systemic
3.4
9.3
48
166
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
14.5
9.3
15
11
X59
ICD-10 Finland
Exposure to unspecified factor
3.0
9.3
61
248
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
38.3
9.1
11
*
G99.2*M50.0
ICD-10 Finland
Cervical disc disorder with myelopathy
38.3
9.1
11
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
38.3
9.1
11
*
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
38.3
9.1
11
*
R13
ICD-10 Finland
Dysphagia
5.0
9.1
29
65
J96.1
ICD-10 Finland
Chronic respiratory failure
8.5
9.0
19
24
M03BX02
ATC
tizanidine; oral
2.4
9.0
145
964
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.4
9.0
33
85
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
13.3
9.0
15
12
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
8.9
67
295
NF1AA
NOMESCO Finland
Hip X-ray examination
4.3
8.9
33
86
K59.0
ICD-10 Finland
Constipation
5.4
8.8
26
53
SPAT1231
SPAT
Assessment of adjustments needed in living environment
14.8
8.8
14
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
8.8
47
165
SPAT1215
SPAT
Assessment of need for medical rehabilitation
6.5
8.7
22
37
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
10.6
8.7
16
16
J01FF01
ATC
clindamycin; systemic
2.6
8.7
73
346
JDB10
NOMESCO Finland
Percutaneous gastrostomy
17.1
8.7
13
8
TAB00
NOMESCO Finland
Lumbar puncture
5.7
8.6
24
46
R53
ICD-10 Finland
Malaise and fatigue
2.9
8.6
57
232
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.0
8.5
27
60
JN4BD
NOMESCO Finland
Extensive body CT
3.6
8.5
39
123
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.2
8.4
46
165
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
8.4
8
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.7
8.4
28
66
SPAT1216
SPAT
Assessment of functional ability
3.2
8.3
46
167
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
5.3
8.2
24
49
RF120
NOMESCO Finland
NA
18.0
8.2
12
7
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
34.7
8.1
10
*
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
34.7
8.1
10
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.6
8.1
23
45
NAG41
NOMESCO Finland
Anterior fusion of cervical spine with fixation
23.0
8.1
11
5
WX882
NOMESCO Finland
High dependency care
7.0
8.1
19
29
Z50.1
ICD-10 Finland
Other physical therapy
5.1
7.9
24
51
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
46.5
7.8
9
*
NAG42
NOMESCO Finland
Posterior fusion of cervical spine with or without fixation
46.5
7.8
9
*
G99.2
ICD-10 Finland
Myelopathy in diseases classified elsewhere
46.5
7.8
9
*
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
8.5
7.7
16
20
XG466
NOMESCO Finland
Sleep oxymetry
6.1
7.7
20
35
N06AA09
ATC
amitriptyline; systemic
3.7
7.7
34
104
S72.4
ICD-10 Finland
Fracture of lower end of femur
19.1
7.7
11
6
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
26.0
7.6
10
*
WX872
NOMESCO Finland
Intensive care
4.5
7.6
26
63
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
7.6
37
123
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
6.4
7.6
19
32
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
7.5
90
503
G99.2*M47.9
ICD-10 Finland
Myelopathy in spondylosis
82.6
7.5
8
*
R52.2
ICD-10 Finland
Other chronic pain
6.6
7.4
18
29
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
11.4
7.4
13
12
N30.9
ICD-10 Finland
Cystitis, unspecified
5.2
7.4
22
46
KCJ00
NOMESCO Finland
Cystostomy
+∞
7.3
7
*
S13.1
ICD-10 Finland
Dislocation of cervical vertebra
+∞
7.3
7
*
34302
ICD-8 Finland
Cerebral spastic infantile paralysis, Tetraplegia spastica
+∞
7.3
7
*
80690
ICD-8 Finland
Fracture and fracture dislocation of vertebral column with spinal cord lesion, Cervicalis, Sequelae
+∞
7.3
7
*
W16
ICD-10 Finland
Diving or jumping into water causing injury other than drowning or submersion
+∞
7.3
7
*
S24.0
ICD-10 Finland
Concussion and oedema of thoracic spinal cord
+∞
7.3
7
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
7.3
7
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.2
7.3
27
71
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.3
7.3
26
66
A41.9
ICD-10 Finland
Sepsis, unspecified
7.0
7.3
17
26
G04AA01
ATC
NA
20.8
7.2
10
5
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
20.8
7.2
10
5
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
12.6
7.2
12
10
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
12.6
7.2
12
10
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.2
7.2
26
67
R5110
SPAT
NA
7.4
7.1
16
23
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.1
7.1
27
73
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
7.0
59
274
TKC22
NOMESCO Finland
Catheterisation instruction
8.7
6.9
14
17
B01AB05
ATC
enoxaparin; parenteral
2.3
6.9
73
384
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
9.8
6.9
13
14
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
9.8
6.9
13
14
R50.9
ICD-10 Finland
Fever, unspecified
2.8
6.8
45
181
TJD20
NOMESCO Finland
Change of gastrostomy tube
41.3
6.8
8
*
C03CA01
ATC
furosemide; systemic
2.3
6.8
76
411
J01MA14
ATC
moxifloxacin; systemic
3.5
6.8
31
98
U04
ICPC
Incontinence urine
6.2
6.7
17
29
V89
ICD-10 Finland
Motor- or nonmotor-vehicle accident, type of vehicle unspecified
23.3
6.7
9
*
R4130
NOMESCO Finland
Speech therapy
8.2
6.7
14
18
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
6.6
37
135
G04BD07
ATC
tolterodine; oral
6.0
6.6
17
30
SPAT1211
SPAT
Application of soft bandage
3.2
6.5
33
113
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
71.7
6.5
7
*
NAJ12
NOMESCO Finland
Posterior reduction of fracture of cervical spine
71.7
6.5
7
*
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
71.7
6.5
7
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
14.8
6.5
10
7
U13
ICPC
Bladder symptom/complaint other
6.9
6.4
15
23
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
6.9
6.4
15
23
XKD00
NOMESCO Finland
Uroflowmetry
2.5
6.4
52
238
N03AF02
ATC
oxcarbazepine; oral
5.8
6.4
17
31
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
8.5
6.4
13
16
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.4
6.4
22
54
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
11.5
6.4
11
10
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
4.8
6.3
20
45
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
+∞
6.3
6
*
NDT99
NOMESCO Finland
Other operation on wrist or hand
+∞
6.3
6
*
34403
ICD-8 Finland
Other cerebral paralysis, Laesia medullaris non traumatica, sequelae
+∞
6.3
6
*
3432A
ICD-9 Finland
Infantile cerebral palsy, Quadriplegic[CP-OIREYHTYMÄ,TETRAPLEGIA SPASTICA]
+∞
6.3
6
*
P21.0
ICD-10 Finland
Severe birth asphyxia
+∞
6.3
6
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.2
6.2
18
37
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.8
6.2
39
154
N03AX09
ATC
lamotrigine; oral
4.2
6.2
22
56
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.2
6.2
22
56
G47.3
ICD-10 Finland
Sleep apnoea
2.4
6.1
57
281
G04BD08
ATC
solifenacin; oral
4.0
6.1
23
62
S17
ICPC
Abrasion/scratch/blister
7.6
6.0
13
18
N29
ICPC
Neurological sympt/complt other
7.6
6.0
13
18
TQW11
NOMESCO Finland
Vacuum treatment of wound
7.6
6.0
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026008) Bacteria identified in Urine by Culture
142
514
4.98
36.24
8.1
3.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
135
558
4.02
26.88
7.9
4.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
88
308
3.84
21.58
2.3
1.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
102
433
3.26
18.01
3.7
2.5
e6/l
5.4
5.5
0.02
91
380
(3026782) Osmolality of Urine
98
410
3.26
17.68
4.5
2.8
mosm/kgh2o
486.4
577.0
4.19
91
348
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
12
14.16
16.94
4.2
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
116
564
2.94
15.72
6.2
3.0
e6/l
0.5
0.4
0.22
100
418
(3007853) Bacteria identified in Skin by Aerobe culture
69
249
3.43
15.63
3.3
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
45
122
4.26
15.39
6.2
5.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
32
7.43
14.66
4.7
2.9
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
15
13
12.20
14.55
4.2
1.1
mmol/l
1.9
1.7
0.26
15
13
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
124
4.08
14.25
1.9
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
110
548
2.77
13.87
6.4
2.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
96
446
2.85
13.83
3.2
2.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
47
143
3.80
13.66
2.0
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
131
720
2.69
13.50
6.8
3.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
118
619
2.69
13.31
6.7
3.2
e6/l
28.8
164.1
0.70
106
474
(3044640) Blood type and Crossmatch panel - Blood
115
596
2.69
13.29
3.5
2.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
70
285
3.01
12.72
3.1
2.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
128
711
2.61
12.70
8.2
3.8
e6/l
70.0
59.3
0.23
108
510
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
39
110
4.01
12.57
2.6
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
10
12.54
11.82
1.2
1.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
116
632
2.53
11.76
3.0
2.5
u/l
47.0
55.4
3.14
107
585
(3016018) Differential panel - Cerebral spinal fluid
13
13
10.48
11.43
5.5
4.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
71
4.48
11.21
1.4
2.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
14
9.73
10.85
1.2
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
14
9.73
10.85
1.2
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
134
801
2.42
10.85
7.2
7.6
inr
1.2
1.2
0.15
36
241
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
141
866
2.41
10.69
10.9
7.3
mmol/l
1.2
1.2
0.15
126
785
(42870588) Differential panel, method unspecified - Blood
118
675
2.39
10.45
7.3
6.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
15
9.08
10.32
1.2
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
148
949
2.33
9.89
11.1
7.6
mmol/l
1.2
1.2
0.65
130
794
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
160
1061
2.36
9.88
6.9
6.7
umol/l
11.1
12.3
0.40
149
1007
(3019225) pH of Specimen
45
164
3.12
9.75
3.5
4.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
134
834
2.28
9.49
5.5
4.7
g/l
32.5
35.7
5.45
124
781
(3012095) Magnesium [Moles/volume] in Serum or Plasma
69
321
2.58
9.45
3.6
4.4
mmol/l
0.8
0.8
0.08
62
304
(3037467) Urinalysis macro (dipstick) panel - Urine
185
1336
2.40
8.96
10.2
4.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
36
5.30
8.75
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
36
5.30
8.75
1.6
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
69
333
2.47
8.68
5.8
2.7
e6/l
1.0
1.0
0.02
49
188
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
52
219
2.73
8.63
2.9
1.8
—
—
—
0
0
(4024509)
11
13
8.80
8.52
1.6
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
87
471
2.29
8.40
2.4
2.1
mg/l
3.2
3.1
0.12
68
410
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
120
749
2.14
8.06
3.4
2.3
nmol/l
86.0
75.5
2.45
104
664
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
51
221
2.63
7.97
3.0
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
143
957
2.13
7.97
8.1
6.3
%
58.8
56.9
0.91
135
900
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
24
66
3.91
7.94
1.6
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
69
347
2.36
7.85
1.9
1.7
nmol/l
1118.4
1221.8
0.42
51
254
(3019069) Monocytes/100 leukocytes in Blood
142
952
2.11
7.82
8.6
6.7
%
8.3
8.8
1.20
134
897
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
135
890
2.10
7.76
4.9
4.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
64
313
2.39
7.74
6.7
3.0
e6/l
3.2
1.6
0.31
46
170
(3006504) Eosinophils/100 leukocytes in Blood
141
946
2.10
7.72
8.2
6.4
%
2.7
2.8
0.23
132
884
(1761868) Lipid panel - Serum or Plasma
32
746
0.35
7.69
2.2
2.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
148
1019
2.08
7.46
7.7
6.3
e9/l
0.0
0.0
0.30
124
884
(3022096) Basophils/100 leukocytes in Blood
137
920
2.06
7.36
8.1
6.5
%
0.6
0.7
1.27
126
861
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
60
3.92
7.36
2.0
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
143
976
2.06
7.34
8.2
6.5
%
26.5
27.7
0.52
135
915
(3019198) Lymphocytes [#/volume] in Blood
149
1035
2.06
7.26
7.9
6.4
e9/l
1.9
2.0
0.17
127
921
(3001604) Monocytes [#/volume] in Blood
146
1016
2.02
6.97
7.5
6.3
e9/l
0.6
0.6
0.12
123
879
(3013115) Eosinophils [#/volume] in Blood
149
1047
2.02
6.89
8.0
6.6
e9/l
0.2
0.2
0.06
130
928
(3035350) Ketones [Presence] in Urine by Test strip
139
978
1.93
6.15
6.8
3.5
estimate
0.0
0.0
0.00
38
177
(3013650) Neutrophils [#/volume] in Blood by Automated count
159
1170
1.95
6.14
8.5
10.0
e9/l
4.4
4.2
0.55
137
1022
(3003396) Base excess in Arterial blood by calculation
49
236
2.33
6.04
15.6
10.1
mmol/l
2.5
1.1
1.22
41
187
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
6
15.48
5.94
1.2
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
111
738
1.89
5.72
2.4
1.9
pmol/l
81.9
92.9
1.85
64
386
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
194
1550
2.05
5.66
9.9
7.6
u/l
87.5
78.6
1.11
181
1446
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
234
2.24
5.34
4.1
4.5
%
32.3
31.5
0.19
35
147
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
8
11.60
5.33
2.6
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
193
2.34
5.31
4.7
3.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
72
428
1.95
5.11
1.9
2.1
mg/l
1.7
1.3
0.25
54
347
(3023410) Appearance of Cerebral spinal fluid
10
19
5.44
5.08
3.5
3.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
9
10.31
5.06
1.2
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
38
177
2.35
5.03
1.8
2.8
e9/l
60.0
68.2
0.86
28
136
(3001122) Ferritin [Mass/volume] in Serum or Plasma
118
824
1.80
5.03
3.1
2.6
ug/l
119.6
135.1
0.41
97
758
(3021601) Nitrite [Presence] in Urine by Test strip
135
982
1.80
5.01
9.1
4.8
estimate
0.0
0.0
0.00
37
180
(3009261) Glucose [Presence] in Urine by Test strip
136
994
1.79
4.94
7.0
3.5
estimate
0.0
0.0
0.00
38
168
(3012544) pH of Venous blood
41
200
2.25
4.88
5.0
5.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
90
590
1.81
4.66
3.0
3.7
ng/l
1180.3
1264.2
0.10
75
491
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
59
3.21
4.61
1.3
1.3
ug/g
252.3
307.1
0.57
11
36
(4027681)
9
11
8.43
4.60
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
22
82
2.84
4.55
2.0
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
46
244
2.08
4.44
1.6
2.6
ug/g
134.3
129.9
0.04
35
202
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
165
1952
0.56
4.41
4.2
4.3
mmol/l
1.4
1.4
0.83
141
1784
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
171
2003
0.56
4.40
4.3
4.8
mmol/l
2.6
2.8
1.00
147
1825
(3022217) INR in Platelet poor plasma by Coagulation assay
45
239
2.07
4.32
13.8
23.6
inr
1.0
1.3
—
5
27
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
6
11.94
4.30
6.1
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
31
143
2.33
4.19
19.4
9.5
mmol/l
26.3
25.0
1.10
31
143
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
16
5.79
3.69
3.4
2.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
43
238
1.97
3.68
1.7
2.8
%
1.7
1.7
0.19
38
216
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
9
7.96
3.58
1.1
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
70
457
1.73
3.55
6.1
3.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
29
142
2.18
3.42
9.4
7.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
171
1965
0.61
3.33
4.0
4.3
mmol/l
4.4
4.6
1.65
147
1802
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
60
2.78
3.29
2.1
2.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
7
8.74
3.28
1.3
1.6
ug/l
117.5
143.7
—
6
7
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
41
233
1.91
3.25
3.2
3.6
umol/l
10.3
9.8
0.04
30
209
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
108
806
1.59
3.20
5.5
3.8
ng/l
35.6
38.0
0.08
95
567
(3014271) Vancomycin [Susceptibility]
7
11
6.51
3.20
3.3
2.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
67
445
1.69
3.16
1.7
1.5
nmol/l
22.7
20.7
0.42
55
382
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
39
3.18
3.13
1.5
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
25
120
2.20
3.10
1.2
1.3
—
24.8
—
0
10
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
164
1894
0.62
3.10
3.8
3.9
mmol/l
1.2
1.3
1.18
138
1729
(3004588) Protein electrophoresis panel - Serum or Plasma
26
127
2.17
3.10
1.6
2.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
34
3.34
3.09
1.5
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
57
365
1.72
3.06
3.7
3.4
ng/l
35.9
225.0
2.03
43
283
(3000991) Gas panel - Venous blood
34
186
1.96
3.01
18.4
10.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
12
41
3.02
2.90
3.3
2.7
%
17.4
15.2
—
6
20
(3018418) pH of Serum or Plasma
78
553
1.59
2.81
4.6
3.9
ph
7.4
7.4
0.26
19
108
(1616796) Gas panel - Central venous blood
12
43
2.88
2.68
8.1
3.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
76
541
1.58
2.68
8.0
3.6
estimate
0.0
0.0
0.00
37
172
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
32
3.21
2.67
1.6
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
13
49
2.74
2.66
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
15
4.77
2.61
3.0
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
158
1.94
2.61
1.1
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
62
2.51
2.59
1.1
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
39
2.90
2.51
3.4
4.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
57
2.54
2.49
3.3
6.0
u/ml
0.2
0.3
—
9
31
(3000494) Fungus identified in Specimen by Culture
39
239
1.75
2.44
1.7
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
77
2.29
2.43
2.4
2.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
14
58
2.50
2.41
3.6
4.2
g/l
0.5
0.2
—
6
30
(40761536) Microorganisms panel - Urine sediment
29
163
1.88
2.39
8.8
3.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
8
6.35
2.38
1.2
1.0
—
—
—
0
0
(3013512) EKG study
78
573
1.52
2.36
4.2
3.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
107
2.05
2.28
25.9
14.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
18
3.97
2.27
1.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
18
3.97
2.27
1.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
18
3.97
2.27
1.0
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
48
318
1.63
2.26
2.9
2.2
umol/l
10.2
14.2
3.27
42
294
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
62
437
1.55
2.25
1.3
1.3
u/ml
0.7
1.6
1.00
16
107
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
95
2.08
2.17
2.3
2.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
19
3.76
2.16
1.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
19
3.76
2.16
1.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
19
3.76
2.16
1.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
111
892
1.43
2.09
14.2
10.5
e9/l
0.0
0.0
0.24
87
729
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
10
5.07
2.08
1.2
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
50
2.47
2.06
4.5
3.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
38
2.70
2.03
1.5
3.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
57
2.35
2.01
1.5
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
64
2.26
1.98
1.2
2.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
21
3.40
1.98
1.6
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
84
649
1.44
1.93
3.6
3.5
u/l
42.6
31.4
0.73
77
619
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
221
0.43
1.92
1.4
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
168
1469
1.42
1.89
5.2
4.0
mm/h
19.0
11.0
5.07
151
1357
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
22
3.24
1.89
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
59
2.27
1.87
1.0
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
27
161
1.76
1.87
5.3
3.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
40
2.56
1.86
2.5
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
67
501
1.46
1.82
7.9
7.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
32
202
1.67
1.82
21.9
10.2
g/l
116.6
123.6
1.27
32
195
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
35
2.63
1.82
1.3
5.1
—
5308.4
—
0
5
(3023419) Bacteria identified in Sputum by Culture
8
29
2.81
1.80
5.6
3.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
12
54
2.28
1.77
1.7
2.9
mg/l
32.9
31.9
0.06
12
44
(3034860) Kappa light chains.free [Mass/volume] in Serum
12
54
2.28
1.77
1.7
2.9
mg/l
41.9
65.6
0.45
12
44
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
29
180
1.69
1.76
2.3
2.8
u/l
25.9
34.1
1.13
22
152
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
30
2.72
1.74
1.8
1.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
24
2.97
1.73
1.1
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
7
24
2.97
1.73
1.3
1.2
nmol/l
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
55
402
1.47
1.67
1.3
1.5
g/l
2.3
2.5
0.42
32
240
(44790048)
7
25
2.85
1.66
1.7
1.8
—
—
—
0
0
(44806118)
7
25
2.85
1.66
1.7
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
25
2.85
1.66
1.7
1.5
—
—
—
0
0
(44790049)
7
25
2.85
1.66
1.7
1.8
—
—
—
0
0
(44790047)
7
25
2.85
1.66
1.7
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
79
620
1.40
1.64
2.4
3.3
mmol/l
2.3
2.3
3.14
65
552
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
14
3.62
1.62
1.2
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
14
3.62
1.62
1.2
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
14
3.62
1.62
1.4
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
14
3.62
1.62
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
14
3.62
1.62
1.2
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
54
397
1.46
1.59
1.6
1.7
pmol/l
444.6
452.3
0.07
44
341
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
50
2.25
1.59
1.5
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
204
0.47
1.57
1.1
2.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
15
3.38
1.53
4.2
2.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
27
2.64
1.52
1.4
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
224
0.51
1.47
1.5
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
11
52
2.17
1.46
1.2
1.3
—
1.8
—
0
12
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
11
52
2.17
1.46
1.2
1.3
—
2.9
—
0
10
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
28
2.54
1.46
1.4
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
28
2.54
1.46
1.4
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
28
2.54
1.46
1.3
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
240
1.53
1.45
8.5
7.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
40
2.29
1.41
1.6
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
40
284
1.48
1.41
3.2
2.2
%
17.0
24.5
4.32
31
252
(3044889) 12 lead EKG panel
118
1358
0.76
1.41
3.6
3.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
94
775
1.34
1.40
8.4
3.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
29
2.45
1.40
1.4
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
29
2.45
1.40
1.4
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
41
2.24
1.38
2.1
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
41
294
1.47
1.38
3.2
2.2
g/l
2.3
2.3
0.31
36
274
(3002179) Metamyelocytes/100 leukocytes in Blood
24
152
1.64
1.37
2.1
4.7
%
0.2
0.4
—
5
45
(3017732) Neutrophils [#/volume] in Blood
23
144
1.66
1.37
5.7
2.6
e9/l
3.9
3.8
0.02
15
111
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
17
2.98
1.36
1.4
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
47
2.17
1.35
1.0
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
67
527
1.37
1.35
2.3
2.8
umol/l
324.6
4848.8
1.58
52
453
(3022621) pH of Urine by Test strip
20
121
1.71
1.35
3.0
2.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
42
2.18
1.35
2.1
5.3
—
859.7
—
0
6
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
43
2.13
1.31
1.2
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
24
2.53
1.31
1.0
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
24
2.53
1.31
1.3
1.2
nmol/l
0.5
0.5
—
6
18
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
69
1.93
1.31
1.8
1.8
g/l
2.9
3.1
—
8
54
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
161
1442
1.32
1.30
3.6
3.4
pmol/l
15.6
14.8
2.52
142
1310
(3025159) Blasts/100 leukocytes in Blood
24
156
1.59
1.25
2.9
4.8
%
0.0
0.2
—
6
51
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
25
2.43
1.25
1.2
2.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
45
2.04
1.24
1.2
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
19
2.66
1.22
1.4
6.3
%
12.4
11.5
—
5
19
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
19
2.66
1.22
1.0
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
198
0.54
1.22
1.5
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
26
2.34
1.19
1.8
2.1
—
—
—
0
0
(3000492) Spirometry study
11
196
0.54
1.18
1.2
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
33
0.00
1.17
0.0
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
33
0.00
1.17
0.0
1.1
—
13.9
—
0
26
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
145
1292
1.28
1.16
3.3
3.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
182
0.53
1.15
1.1
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
40
2.03
1.13
1.9
2.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
21
2.41
1.09
2.2
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
21
2.41
1.09
4.2
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
32
2.22
1.09
2.7
1.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
7
32
2.22
1.09
2.6
5.0
u/ml
143.9
773.4
—
7
32
(3002256) Pathology report gross observation
32
230
1.45
1.08
1.6
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
52
1.96
1.07
2.0
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
52
1.96
1.07
2.0
2.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
28
197
1.47
1.05
1.8
2.1
nmol/l
13.0
13.8
0.14
22
176
(3013290) Carbon dioxide [Partial pressure] in Blood
9
47
1.95
1.03
11.8
3.3
kpa
5.1
5.2
—
9
47
(3027315) Oxygen [Partial pressure] in Blood
9
47
1.95
1.03
11.8
3.3
kpa
8.6
8.5
—
9
47
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
76
1.75
1.01
1.8
1.7
g/l
4.3
3.9
—
8
53
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
76
1.75
1.01
1.8
1.7
g/l
7.3
7.5
—
8
56
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
76
1.75
1.01
1.8
1.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
17
108
1.62
0.99
4.1
3.8
%
1.3
1.3
0.01
17
108
(21494890) Protein electrophoresis panel - 24 hour Urine
5
23
2.20
0.98
1.0
2.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
36
1.97
0.98
3.9
4.2
%
76.1
63.3
—
7
36
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
36
1.97
0.98
2.9
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
214
2028
1.34
0.95
35.9
14.3
mg/l
30.8
24.2
1.89
197
1610
(3021440) Promyelocytes/100 leukocytes in Blood
23
160
1.48
0.92
2.8
4.9
%
0.0
0.2
—
6
56
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
56
680
0.77
0.92
3.5
4.4
%
18.1
20.8
0.88
30
322
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
28
2.17
0.92
1.3
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
40
309
1.35
0.91
1.3
1.3
u/ml
206.5
6.7
—
8
121
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
63
1.78
0.91
1.2
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
152
1386
1.24
0.91
4.3
3.2
u/l
49.5
48.0
0.12
139
1298
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
42
1.93
0.89
2.8
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
171
1829
0.80
0.87
5.9
5.8
mmol/mol
40.7
40.1
0.25
150
1703
(3021901) Oxygen saturation in Capillary blood
8
44
1.84
0.86
3.8
3.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
31
1.96
0.85
2.8
1.8
—
—
—
0
0
(4010399)
22
156
1.45
0.82
1.4
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
47
1.72
0.81
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
106
1.54
0.81
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
58
1.75
0.81
1.0
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
24
174
1.42
0.80
2.8
4.7
%
0.3
0.9
—
6
64
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
33
1.84
0.79
3.2
4.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
99
0.50
0.79
1.4
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
40
1.77
0.72
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
40
1.77
0.72
1.1
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
26
1.94
0.71
2.8
4.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
27
1.87
0.69
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
368
0.76
0.67
1.2
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
28
1.80
0.66
1.2
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
21
155
1.39
0.65
1.1
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
16
112
1.46
0.65
1.1
1.2
iu/ml
171.3
145.5
—
6
39
(3019150) Specific gravity of Urine by Refractometry
52
438
1.24
0.64
8.1
3.6
kg/l
1.0
1.0
—
8
60
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
22
0.00
0.59
0.0
2.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
0
23
0.00
0.58
0.0
1.9
—
6.6
—
0
14
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
37
1.64
0.56
2.3
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
37
1.64
0.56
1.2
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
62
1.47
0.53
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
62
1.47
0.53
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
62
1.47
0.53
1.0
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14
100
1.42
0.53
2.9
2.9
pmol/l
4.7
4.5
0.27
14
89
(40768797) Stomach Pathology biopsy report
31
252
1.26
0.53
1.3
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
42
494
0.82
0.53
2.5
2.9
ug/l
0.7
0.8
0.52
29
318
(3010813) Leukocytes [#/volume] in Blood
219
2250
0.81
0.50
43.1
20.6
e9/l
7.3
6.8
2.55
212
2184
(3026361) Erythrocytes [#/volume] in Blood
219
2249
0.81
0.49
43.0
20.5
e12/l
4.4
4.6
5.07
212
2187
(3000330) Specific gravity of Urine by Test strip
14
102
1.39
0.48
4.9
3.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
219
2248
0.82
0.47
43.2
20.6
e9/l
249.6
246.9
0.20
213
2187
(3041096) Erythrocytes [Presence] in Urine by Automated
62
548
1.17
0.47
7.8
3.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
219
2247
0.82
0.46
42.9
20.5
fl
90.8
90.7
0.04
214
2215
(3020891) Body temperature
12
86
1.41
0.45
6.1
5.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
78
1.43
0.44
1.3
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
32
1.57
0.42
1.6
2.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
8
58
1.39
0.42
27.4
13.6
mmol/l
1.2
1.3
—
8
50
(3000060) B lymphocytes [#/volume] in Blood
0
16
0.00
0.41
0.0
2.0
—
560.0
—
0
7
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
16
0.00
0.41
0.0
3.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
2.9
—
54.5
—
0
17
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
185
1779
1.15
0.41
4.7
4.1
mu/l
1.8
1.9
0.76
167
1611
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
105
0.66
0.40
1.3
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
12.8
—
1567.2
—
0
18
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
35
1.44
0.39
1.6
2.9
e9/l
4.3
4.9
—
5
35
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
19
0.00
0.39
0.0
1.3
—
10.4
—
0
5
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
36
1.40
0.38
1.6
3.3
%
56.6
58.7
—
5
36
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
42
1.44
0.36
3.2
1.4
—
—
—
0
0
(3039000) Anion gap in Blood
6
46
1.31
0.33
34.8
15.1
mmol/l
12.8
11.7
—
6
40
(3018572) Chloride [Moles/volume] in Blood
6
46
1.31
0.33
34.8
15.1
mmol/l
101.7
105.0
—
6
40
(3009508) Creatinine [Moles/volume] in Urine
65
594
1.13
0.32
3.1
3.2
mmol/l
6.4
7.9
1.67
51
490
(40760892) CBC W Ordered Manual Differential panel - Blood
41
461
0.87
0.32
3.6
4.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
189
1832
1.12
0.31
26.0
13.1
ml/min/173m2
96.2
82.1
8.84
171
1494
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
53
1.33
0.31
1.0
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
58
528
1.13
0.31
1.3
1.4
—
—
—
0
0
(4035726)
14
172
0.80
0.28
1.5
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
38
339
1.14
0.27
1.8
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
32
282
1.15
0.27
1.5
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
79
738
1.10
0.27
2.6
2.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
180
1849
0.91
0.25
31.3
14.9
%
38.2
40.5
1.84
100
1369
(3008898) HLA-B27 [Presence]
6
83
0.72
0.24
1.0
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
186
1906
0.91
0.24
4.3
4.4
mmol/l
6.0
6.0
0.17
157
1732
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.4
—
0
5
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.3
—
0
5
(3024263) Appearance of Synovial fluid
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
13
0.00
0.21
0.0
3.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
16
136
1.19
0.20
1.3
1.8
g/l
1.2
1.2
0.03
16
123
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
108
1.21
0.20
1.1
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
48
1.26
0.20
1.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
212
2150
0.92
0.16
14.5
10.3
u/l
31.5
26.9
0.68
205
2065
(3000764) Benzodiazepines [Presence] in Urine
6
77
0.77
0.16
1.5
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
78
0.76
0.16
1.5
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
78
0.76
0.16
1.5
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
78
0.76
0.16
1.5
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
47
500
0.93
0.15
1.6
1.7
mmol/l
1.5
1.4
0.56
40
422
(3007930) Methemoglobin/Hemoglobin.total in Blood
9
82
1.10
0.15
24.7
10.4
%
1.0
0.9
—
9
74
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
9
82
1.10
0.15
24.7
10.4
%
1.8
1.5
—
9
75
(1002224) Polysomnography panel
8
100
0.79
0.14
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
212
2095
1.07
0.12
27.5
13.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
25
231
1.09
0.11
1.2
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
57
1.05
0.08
1.5
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
57
1.05
0.08
1.0
1.1
—
3.6
—
0
5
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
83
852
0.96
0.08
5.2
4.8
ug/l
1.6
2.3
2.02
76
751
(3003327) Ova and parasites identified in Stool by Light microscopy
7
66
1.06
0.08
1.0
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
67
1.05
0.08
1.3
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
7
68
1.03
0.08
1.3
1.5
mu/l
215.7
317.3
—
7
62
(3016879) Cocaine [Presence] in Urine
6
72
0.83
0.07
1.5
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
21
197
1.07
0.06
3.7
4.5
ug/l
7.4
30.6
0.53
16
158
(3020682) Albumin/Creatinine [Ratio] in Urine
59
576
1.03
0.04
3.9
4.1
mg/mmol
15.4
8.5
0.51
40
376
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
34
332
1.03
0.02
1.4
1.2
iu/ml
21.0
38.6
—
9
104
(3012516) Albumin [Mass/volume] in Urine
54
548
0.98
0.01
3.1
3.3
mg/l
889.3
170.9
0.40
37
361
(3017143) Hepatitis C virus Ab [Presence] in Serum
25
243
1.03
0.01
1.5
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
14
142
0.99
0.00
1.1
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
105
0.95
0.00
1.0
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
5.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.1
—
124.8
—
0
8
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
41.0
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
1.7
—
1.2
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
16.9
—
0
5
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
3.0
—
10945.2
—
0
5
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
8
0.00
0.00
0.0
8.5
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
8
0.00
0.00
0.0
42.4
—
6.6
—
0
8
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
4.9
—
53.7
—
0
8
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
1.6
—
1.2
—
0
8
(21494814) CD8 cells/100 lymphocytes in Specimen
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
66
0.91
0.00
1.8
1.7
pmol/l
143.3
242.4
—
6
60
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
19.4
—
0.6
—
0
5
(3011288) Drugs identified in Urine by Screen method
5
50
1.00
0.00
1.6
2.2
—
—
—
0
0
(4034850)
6
69
0.87
0.00
10.8
10.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
9.4
—
0
8
(1761482) Bacteria [#/volume] in Urine by Culture
6
61
0.98
0.00
7.8
4.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_TETRAPLE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_TETRAPLE | 4.524 [3.57, 5.73] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.319 |
During the follow-up period (1.1.1998 — 31.12.2019), 396 out of 1131 females with G6_TETRAPLE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_TETRAPLE | 4.224 [3.6, 4.96] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 782 out of 1973 males with G6_TETRAPLE died.
Mortality risk
Mortality risk for people of age
years, who have G6_TETRAPLE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.438% | 0.861% |
| 5 | 2.374% | 5.06% |
| 10 | 6.461% | 12.798% |
| 15 | 11.992% | 21.439% |
| 20 | 20.747% | 34.276% |
Relationships between endpoints
↥Index endpoint: G6_TETRAPLE – Tetraplegia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data